Search Results - "Brodosi, Lucia"

Refine Results
  1. 1
  2. 2

    Nutrition in Patients with Type 2 Diabetes: Present Knowledge and Remaining Challenges by Petroni, Maria Letizia, Brodosi, Lucia, Marchignoli, Francesca, Sasdelli, Anna Simona, Caraceni, Paolo, Marchesini, Giulio, Ravaioli, Federico

    Published in Nutrients (01-08-2021)
    “…Unhealthy behaviours, including diet and physical activity, coupled with genetic predisposition, drive type 2 diabetes (T2D) occurrence and severity; the…”
    Get full text
    Journal Article
  3. 3

    NEUROD1 mutation in an Italian patient with maturity onset diabetes of the young 6: a case report by Brodosi, Lucia, Baracco, Bianca, Mantovani, Vilma, Pironi, Loris

    Published in BMC endocrine disorders (15-10-2021)
    “…Maturity Onset Diabetes of the Young (MODY) is a monogenic, autosomal, dominant disease that results in beta-cells dysfunction with consequent hyperglycaemia…”
    Get full text
    Journal Article
  4. 4

    Lifestyle Intervention in NAFLD: Long-Term Diabetes Incidence in Subjects Treated by Web- and Group-Based Programs by Petroni, Maria Letizia, Brodosi, Lucia, Armandi, Angelo, Marchignoli, Francesca, Bugianesi, Elisabetta, Marchesini, Giulio

    Published in Nutrients (01-02-2023)
    “…Behavioral programs are needed for prevention and treatment of NAFLD and the effectiveness of a web-based intervention (WBI) is similar to a standard…”
    Get full text
    Journal Article
  5. 5

    The management of transitional care of patients affected by phenylketonuria in Italy: Review and expert opinion by Biasucci, Giacomo, Brodosi, Lucia, Bettocchi, Ilaria, Noto, Davide, Pochiero, Francesca, Urban, Maria Letizia, Burlina, Alberto

    Published in Molecular genetics and metabolism (01-06-2022)
    “…Phenylketonuria (PKU) is a metabolic inherited disorder in which transition from infancy to adult care is particularly difficult and not sufficiently…”
    Get full text
    Journal Article
  6. 6

    Management of patients with phenylketonuria (PKU) under enzyme replacement therapy: An Italian model (expert opinion) by Scala, Iris, Brodosi, Lucia, Rovelli, Valentina, Noto, Davide, Burlina, Alberto

    Published in Molecular genetics and metabolism reports (01-06-2024)
    “…Phenylketonuria (PKU) is a metabolic disorder necessitating lifelong management to prevent severe neurological impairments. This paper synthesises clinical…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Bone marrow derived stem cells for the treatment of end-stage liver disease by Margini, Cristina, Vukotic, Ranka, Brodosi, Lucia, Bernardi, Mauro, Andreone, Pietro

    Published in World journal of gastroenterology : WJG (21-07-2014)
    “…End-stage disease due to liver cirrhosis is an important cause of death worldwide. Cirrhosis results from progressive, extensive fibrosis and impaired…”
    Get full text
    Journal Article
  9. 9

    Anxiety and depression in metabolic-associated steatotic liver disease: relation with socio-demographic features and liver disease severity by Brodosi, Lucia, Stecchi, Michele, Musio, Alessandra, Bazzocchi, Matilde, Risi, Eleonora, Marchignoli, Francesca, Marchesini, Giulio, Petroni, Maria Letizia

    Published in Acta diabetologica (2024)
    “…Purpose We aimed to evaluate the prevalence of anxiety and depression traits in Italian patients with metabolic dysfunction-associated steatotic liver disease…”
    Get full text
    Journal Article
  10. 10

    Risk of binge eating disorder in patients with metabolic dysfunction-associated steatotic liver disease by Brodosi, Lucia, Stecchi, Michele, Marchignoli, Francesca, Lucia, Elisabetta, Magnani, Lucia, Guarneri, Valeria, Petroni, Maria Letizia, Marchesini, Giulio, Pironi, Loris

    Published in Eating and weight disorders (06-12-2023)
    “…Purpose Very few data exist on the association between metabolic dysfunction-associated steatotic liver disease (MASLD) and eating disorders. The study aimed…”
    Get full text
    Journal Article
  11. 11
  12. 12

    NASH: A glance at the landscape of pharmacological treatment by Brodosi, Lucia, Marchignoli, Francesca, Petroni, Maria Letizia, Marchesini, Giulio

    Published in Annals of hepatology (01-09-2016)
    “…AbstractThe role of nonalcoholic fatty liver disease, namely nonalcoholic steatohepatitis (NASH), as risk factor for liver- and non-liver-related morbidity and…”
    Get full text
    Journal Article
  13. 13

    Pathophysiology of Nonalcoholic Fatty Liver Disease: Lifestyle-Gut-Gene Interaction by Mazzotti, Arianna, Caletti, Maria Turchese, Sasdelli, Anna Simona, Brodosi, Lucia, Marchesini, Giulio

    Published in Digestive diseases (Basel) (01-01-2016)
    “…The accumulation of fat droplets in the hepatic parenchyma is driven by several factors, synergistically acting to increase triglyceride flow to the liver…”
    Get more information
    Journal Article
  14. 14

    Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels by Loggi, Elisabetta, Bihl, Florian K, Cursaro, Carmela, Granieri, Camilla, Galli, Silvia, Brodosi, Lucia, Furlini, Giuliano, Bernardi, Mauro, Brander, Christian, Andreone, Pietro

    Published in PloS one (04-06-2013)
    “…The immune impairment characterizing chronic hepatitis B (cHBV) infection is thought to be the consequence of persistent exposure to viral antigens. However,…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report by Gamal, Nesrine, Brodosi, Lucia, Misciali, Cosimo, Patrizi, Annalisa, Vukatana, Gentiana, Malavolta, Nazzarena, Bernardi, Mauro, Andreone, Pietro

    Published in Annals of hepatology (01-03-2014)
    “…AbstractFor the last decade, the combination therapy of pegylated interferon (Peg-IFN) plus ribavirin (RBV) has been considered as the standard of care…”
    Get full text
    Journal Article
  17. 17

    Looking ahead to potential incretin combination therapies for nonalcoholic steatohepatitis in patients with diabetes by Brodosi, Lucia, Petroni, Maria Letizia, Marchesini, Giulio

    Published in Expert opinion on pharmacotherapy (13-06-2023)
    “…There are no drugs approved by regulatory agencies for the treatment of nonalcoholic fatty liver disease (NAFLD); incretin combination therapies are being…”
    Get more information
    Journal Article
  18. 18
  19. 19
  20. 20

    Malnutrition and nutritional therapy in patients with SARS-CoV-2 disease by Pironi, Loris, Sasdelli, Anna Simona, Ravaioli, Federico, Baracco, Bianca, Battaiola, Claudia, Bocedi, Giulia, Brodosi, Lucia, Leoni, Laura, Mari, Giulia Aurora, Musio, Alessandra

    Published in Clinical nutrition (Edinburgh, Scotland) (01-03-2021)
    “…The prevalence of malnutrition and the provided nutritional therapy were evaluated in all the patients with SARS-CoV-2 infection (COVID-19) hospitalized in a…”
    Get full text
    Journal Article